GHP Investment Advisors Inc. Raises Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

GHP Investment Advisors Inc. lifted its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.5% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 86,989 shares of the company’s stock after buying an additional 449 shares during the quarter. GHP Investment Advisors Inc. owned about 0.18% of Prestige Consumer Healthcare worth $6,272,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in PBH. Boston Trust Walden Corp bought a new stake in shares of Prestige Consumer Healthcare during the 3rd quarter valued at $41,785,000. International Assets Investment Management LLC boosted its stake in shares of Prestige Consumer Healthcare by 7,112.5% in the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock worth $83,000 after acquiring an additional 1,138 shares during the period. Private Advisor Group LLC grew its position in shares of Prestige Consumer Healthcare by 15.6% during the third quarter. Private Advisor Group LLC now owns 3,380 shares of the company’s stock worth $244,000 after purchasing an additional 457 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in Prestige Consumer Healthcare by 12.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock valued at $708,000 after purchasing an additional 1,120 shares during the period. Finally, Allspring Global Investments Holdings LLC lifted its holdings in Prestige Consumer Healthcare by 19.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,575,170 shares of the company’s stock worth $113,570,000 after purchasing an additional 255,045 shares in the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. DA Davidson increased their price objective on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Jefferies Financial Group reaffirmed a “hold” rating and set a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $94.20.

Prestige Consumer Healthcare Stock Up 0.3 %

Shares of PBH opened at $73.04 on Friday. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The stock has a market capitalization of $3.62 billion, a price-to-earnings ratio of 17.86, a price-to-earnings-growth ratio of 2.03 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 1 year low of $56.61 and a 1 year high of $75.80. The business’s 50 day simple moving average is $71.82 and its 200-day simple moving average is $69.39.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The company had revenue of $267.10 million for the quarter, compared to the consensus estimate of $260.54 million. During the same quarter in the prior year, the firm earned $1.06 earnings per share. Prestige Consumer Healthcare’s revenue was down 4.4% on a year-over-year basis. As a group, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.43 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.